Literature DB >> 24484338

Reply: rationale for anticoagulant therapy of pulmonary fibrosis.

Imre Noth1, Mitchell A Olman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24484338      PMCID： PMC3977732          DOI： 10.1164/rccm.201307-1328LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; Richard M Silver
Journal:  Arthritis Rheum       Date:  2009-11

Review 2.  Coagulation cascade proteinases in lung injury and fibrosis.

Authors:  Rachel C Chambers; Chris J Scotton
Journal:  Proc Am Thorac Soc       Date:  2012-07

3.  Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; Paul J Nietert; Tanjina Akter; Joanne van Ryn; Richard M Silver
Journal:  Arthritis Rheum       Date:  2011-05

4.  Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.

Authors:  Malgorzata Wygrecka; Miroslava Didiasova; Sebastian Berscheid; Katarzyna Piskulak; Brigitte Taborski; Dariusz Zakrzewicz; Grazyna Kwapiszewska; Klaus T Preissner; Philipp Markart
Journal:  Thromb Haemost       Date:  2013-06-06       Impact factor: 5.249

5.  A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.

Authors:  Imre Noth; Kevin J Anstrom; Sara Bristol Calvert; Joao de Andrade; Kevin R Flaherty; Craig Glazer; Robert J Kaner; Mitchell A Olman
Journal:  Am J Respir Crit Care Med       Date:  2012-05-03       Impact factor: 21.405
  5 in total
  1 in total

1.  Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease.

Authors:  R M Silver; D A Wilson; T Akter; I Atanelishvili; J T Huggins; K Kajdasz; K B Highland; P J Nietert; G S Bogatkevich
Journal:  ACR Open Rheumatol       Date:  2019-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.